Researchers shed light on how to predict which skin cancer patients are most likely to respond to immunotherapy
An international team of UK and US scientists discovered that the activity of macrophages -- a type of white blood cell that engulf pathogens and cancer cells -- can be used to predict whether or not a melanoma patient will respond to immunotherapy. Their findings will help clinicians select treatments that are most likely to be effective for their patients.
